Elleste duet - Information, specialists, frequent questions.

Usage of Elleste duet

Indications: Treatment of menopausal symptoms such as night sweats and hot flushes in women at least one year past the menopause who have an intact uterus. Treatment of the postmenopausal sequelae of oestrogen withdrawal, including atrophic vaginitis and atrophic urethritis. Prophylaxis of postmenopausal osteoporosis in women at risk of developing fractures
Contra Indications: Known or suspected pregnancy. Known, suspected, or past history of breast cancer. Known or suspected oestrogen-dependent neoplasia. Vaginal bleeding of unknown aetiology. Active deep vein thrombosis, thromboembolic disorders, or a history of confirmed venous thromboembolism. Acute or chronic liver disease or history of liver disease where the liver function tests have failed to return to normal. Rotor's syndrome or Dubin-Johnson syndrome. Severe cardiac or renal disease. Hypersensitivity to one or more of the ingredients. Pregnancy and lactation

Adverse and side effects

GI upset, nausea, vomiting, weight gain, breast tenderness and enlargement, breakthrough bleeding, headache, dizziness, impaired liver function, cholestatic jaundice, epistaxis, migraine, thromboembolic disorders, exacerbation of varicose veins, increased blood pressure, transient erythema, generalised pruritus. REASONS FOR IMMEDIATE DISCONTINUATION OF TREATMENT: Occurence of migraine-type headaches for the first time, frequent severe headaches, acute visual disturbances, signs of thrombophlebitis or thromboembolism, or any other possible prodromal symptoms of vascular occlusion. Rise in blood pressure. Jaundice. Pregnancy. Discontinue six weeks before major elective surgery and during immobilisation entailing risk of thrombosis

Special precautions

History or increased risk of thromboembolic disorders. Mild liver function every 8 to 12 weeks. Closely monitor patients with cholelithiasis, otosclerosis, migraine, multiple sclerosis, epilepsy, diabetes, hypertension, porphyria, uterine fibroids, tetany. Examine blood pressure, pelvic organs and breasts (particularly those with fibrocystic disease of the breast or a family history of breast cancer) before and regularly during treatment. If breakthrough bleeding is persistent, perform endometrial assessment, which may include biopsy

Questions about Elleste duet

Our experts have answered 10 questions about Elleste duet

 Sandeep Sharma
Sandeep Sharma
Gynaecologist
Leeds
Yes, the Elleste Conti contains more progesterone (daily) which is causing these side effects. These may settle within 6-8 weeks but if they don't, you can always go back to Elleste Duet.
5 answers

Dr. Joseph Aquilina
Dr. Joseph Aquilina
Gynaecologist, Obstetrician
London
I would give it 3 weeks as a time limit.
1 answers

Dr. Joseph Aquilina
Dr. Joseph Aquilina
Gynaecologist, Obstetrician
London
It is quite normal to have some sort of breakthrough bleeding in the first six months of HRT. The likelihood is that the bleeding will settle on its own but you need to continue taking the tablets.…
1 answers

What professionals prescribe Elleste duet?


All the contents published in Doctoralia.co.uk, especially medical question and answers, are informative and in no case must be considered a substitute for medical advice.